Literature DB >> 21122841

Ovulation rate in adolescents with type 1 diabetes mellitus.

Ethel Codner1, Francisca C Eyzaguirre, Germán Iñiguez, Patricia López, Francisco Pérez-Bravo, Isabel M Torrealba, Fernando Cassorla.   

Abstract

OBJECTIVE: To study ovulation in adolescents with type 1 diabetes (T1D) and the effect of hemoglobin A1c (HbA1c) levels on their ovulatory function.
DESIGN: Prospective investigation.
SETTING: Academic research institute. PATIENT(S): Adolescents with T1D (n=31) and healthy girls (n=52). INTERVENTION(S): Ovulation assessed through the measurement of salivary progesterone (days 13, 18, 23, and 28 of each cycle). MAIN OUTCOME MEASURE(S): Proportion of ovulatory cycles. RESULT(S): A total of 168 and 281 menstrual cycles were studied in the T1D and control girls, respectively. Metabolic control was defined as optimal if HbA1c was <7.5%. The proportion of ovulatory cycles was similar in the TID and control groups (34.5% and 36.3%, respectively). Regression analyses showed that the presence of T1D did not have a statistically significant effect on the ovulatory rate. However, more ovulatory cycles were observed in girls with T1D who had optimal metabolic control compared with those who had insufficient control (51.3% vs. 29.4%). CONCLUSION(S): In adolescent girls, T1D did not affect the rate of ovulation. A higher ovulatory rate was observed in those with optimal control compared with those with insufficient metabolic control, but a substantial proportion of ovulatory cycles were still observed in patients with higher HbA1c levels.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21122841     DOI: 10.1016/j.fertnstert.2010.10.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study.

Authors:  C Kim; R S Miller; B H Braffett; Y Pan; V L Arends; A K Saenger; A Barnie; A V Sarma
Journal:  Clin Endocrinol (Oxf)       Date:  2018-01-26       Impact factor: 3.478

2.  Small Molecule Differentiate PDX1-Expressing Cells Derived from Human Endometrial Stem Cells on PAN Electrospun Nanofibrous Scaffold: Applications for the Treatment of Diabetes in Rat.

Authors:  Saad Gooraninejad; Elham Hoveizi; Kiavash Hushmandi; Sina Gooraninejad; Seyed Reza Fatemi Tabatabaei
Journal:  Mol Neurobiol       Date:  2020-07-07       Impact factor: 5.590

3.  Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls.

Authors:  Lina Saleh Hassan; Rebecca S Monson; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2016-06-30       Impact factor: 4.876

4.  Diabetes, medical comorbidities and couple fecundity.

Authors:  Michael L Eisenberg; Rajeshwari Sundaram; José Maisog; Germaine M Buck Louis
Journal:  Hum Reprod       Date:  2016-09-02       Impact factor: 6.918

Review 5.  Endocrine autoimmune diseases and female infertility.

Authors:  Aritro Sen; Vitaly A Kushnir; David H Barad; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2013-11-05       Impact factor: 43.330

6.  MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency.

Authors:  Zobia Umair; Mi-Ock Baek; Jisue Song; Seona An; Seung Joo Chon; Mee-Sup Yoon
Journal:  Cells       Date:  2022-09-07       Impact factor: 7.666

Review 7.  Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Authors:  Alexia S Peña; Ethel Codner; Selma Witchel
Journal:  Diagnostics (Basel)       Date:  2022-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.